Ureteroscopic management of upper tract transitional cell carcinoma

Urologic Clinics of North America

Volumn 31, Issue 1, 2004, Pages 115-128

  Lam, John S ^a,d   Gupta, Mantu ^a,b,c  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; FLUOROURACIL; MITOMYCIN C; RECOMBINANT ALPHA2 INTERFERON; THIOTEPA;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RISK; CANCER SURGERY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; HOLMIUM LASER; HUMAN; LASER LITHOTRIPSY; NEODYMIUM LASER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PYELOGRAPHY; RADIOGRAPHY; REVIEW; SURGICAL TECHNIQUE; SYMPTOM; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URETEROSCOPY; URINARY TRACT CARCINOMA; URINE CYTOLOGY;

EID: 1242271331     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(03)00099-5     Document Type: Review

References (64)

1. Messing E.M. Urothelial tumors of the urinary tract. Walsh P.C., Retik A.B., Vaughan E.D. Jr., et al. 8th edition Campbell's urology. vol. 3:2002;2765-2773 W.B. Saunders, Philadelphia.
2. Sagalowsky A.I., Jarrett T.W. Management of urothelial tumors of the renal pelvis and ureter. Walsh P.C., Retik A.B., Vaughan E.D. Jr., et al. 8th edition Campbell's urology. vol. 3:2002;2845-2875 W.B. Saunders, Philadelphia.
3. Cookson M.S., Herr H.W., Zhang Z., et al. The treated natural history of high risk superficial bladder cancer: 15 year outcome. J Urol. 158:1997;62-67.
4. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 22:1998;1435-1448.
5. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 52:1998;594-601.
6. Mufti G.R., Gove J.R.W., Badenoch D.F., et al. Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol. 63:1989;135-140.
7. Charbit L., Gendreau M.C., Mee S., et al. Tumors of the upper urinary tract: 10 years experience. J Urol. 146:1991;1243-1246.
8. Keeley F.X., Bibbo M., McCue P.A., et al. Use of p53 in the diagnosis of upper tract transitional cell carcinoma. Urology. 49:1997;181-186.
9. Oldbring J., Hellsten S., Lindholm K., et al. Flow DNA analysis in the characterization of carcinoma of the renal pelvis and ureter. Cancer. 64:1989;2141-2145.
10. Vest S.A. Conservative surgery in certain benign tumors of the ureter. J Urol. 53:1945;97-120.
11. Ferris D.O., Dent R.V. Epithelioma of the pelvis of a solitary kidney treated by electrocoagulation. J Urol. 59:1948;577.
12. Johnson D.E., Babaian R.J. Conservative surgical management for noninvasive distal ureteral carcinoma. Urology. 13:1979;365-367.
13. Mazeman E. Tumours of the upper urinary tract calyces, renal pelvis and ureter. Eur Urol. 2:1976;120-128.
14. Ziegelbaum M., Novick A.C., Streem S.B., et al. Conservative surgery for transitional cell carcinoma of the renal pelvis. J Urol. 138:1987;1146-1149.
15. Geerdsen J. Tumours of the renal pelvis and ureter: symptomatology, diagnosis, treatment and prognosis. Scand J Urol Nephrol. 13:1979;287-290.
16. Fein A.B., McClennan B.L. Solitary filling defects of the ureter. Semin Roentgenol. 21:1986;201-213.
17. Malek R.S., Aquilo J.J., Hattery R.R. Radiolucent filling defects of the renal pelvis: classification and report of unusual cases. J Urol. 114:1975;508-513.
18. Lantz E.J., Hattery R.R. Diagnostic imaging of urothelial cancer. Urol Clin North Am. 11:1984;576-583.
19. Dodd L.G., Johnston W.W., Robertson C.N., et al. Endoscopic brush cytology of the upper urinary tract: evaluation of its efficacy and potential limitations in diagnosis. Acta Cytol. 41:1997;377-384.
20. Sadek S., Soloway M.S., Hook S., et al. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer. J Urol. 161:1999;77-79.
21. Leistenschneider W., Nagel R. Lavage cytology of the renal pelvis and ureter with special reference to tumors. J Urol. 124:1980;597-600.
22. Gittes R.F. Retrograde brushing and nephroscopy in the diagnosis of upper tract urothelial cancer. Urol Clin North Am. 11:1980;617-622.
23. Blute M.L., Segura J.W., Patterson D.E. Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer. J Urol. 141:1989;1298-1301.
24. Grasso M., Fraiman M., Levine M. Ureteroscopic diagnosis and treatment of upper urinary tract urothelial malignancies. Urology. 54:1999;240-246.
25. Grossman H.B., Schwartz S.L., Konnak J.W. Ureteroscopic diagnosis and treatment of urothelial carcinoma of the ureter and renal pelvis. J Urol. 148:1992;275-277.
26. Huffman J.L., Bagley D.H., Lyon E.S., et al. Endoscopic diagnosis and treatment of upper tract urothelial tumors: a preliminary report. Cancer. 55:1985;1422-1428.
27. Streem S.B., Pontes J., Novick A.C., et al. Ureteropyeloscopy in the evaluation of upper tract filling defects. J Urol. 136:1986;383-385.
28. Conlin M.J., Marberger M., Bagley D.H. Ureteroscopy: development and instrumentation. Urol Clin North Am. 24:1997;25-42.
29. Guarnizo E., Pavlovich C.P., Seiba M., et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multibiopsy approach. J Urol. 163:2000;52-55.
30. Keeley F.X., Kulp D.A., Bibbo M., et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 157:1997;33-37.
31. Bales G.T., Lyon E.S., Gerber G.S. Conservative management of transitional cell carcinoma of the kidney and ureter. Diagn Ther Endosc. 1:1995;121-123.
32. Bagley D.H., Liu J.B., Goldberg B.B. The use of endoluminal ultrasound of the ureter. Semin Urol. 10:1992;194-198.
33. Sarosdy M.D., Pisters L.L., Carroll P.R., et al. Bropirimine immunotherapy of upper urinary tract carcinoma in situ. Urology. 48:1996;28-32.
34. Sharpe J.R., Duffy G., Chin J.L. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol. 149:1993;457-460.
35. Studer U.E., Casanove G., Kraft R., et al. Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. J Urol. 142:1989;975-977.
36. Gerber G.S., Lyon E.S. Endourological management of upper tract urothelial tumors. J Urol. 150:1993;2-7.
37. Huang A., Low R.K., White R.D. Nephrostomy tract tumor seeding following percutaneous manipulation of a urethral carcinoma. J Urol. 153:1995;1041-1042.
38. Grasso M., Bagley D.H. A 7.5/8.2 F actively deflectable, flexible ureteroscope: a new therapeutic upper urinary tract endoscopy. Urology. 43:1994;435-441.
39. Bagley D.H. Ureteroscopic laser treatment of upper urinary tract tumors. J Clin Laser Med Surg. 16:1998;55-59.
40. Schmeller N.T., Hofstetter A.G. Laser treatment of ureteral tumors. J Urol. 141:1989;840-843.
41. Lim D.J., Shattuck M.C., Cook W.A. Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureteroscopy. J Urol. 149:1993;109-111.
42. Bian Y., Ehya H., Bagley D.H. Cytologic diagnosis of upper urinary tract neoplasms by ureteroscopic sampling. Acta Cytol. 39:1995;733-740.
43. Keeley F.X. Jr., Bibbo M., Bagley D.H. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. 157:1997;1560-1565.
44. Martinez-Pineiro J.A., Garcia Matres M.J., Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol. 156:1996;377-385.
45. Tawfiek E.R., Bagley D.H. Upper tract transitional cell carcinoma. Urology. 50:1997;321-329.
46. Elliott D.S., Blute M.L., Patterson D.E., et al. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology. 47:1996;819-825.
47. Eastham J.A., Huffman J.L. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. J Urol. 150:1993;324-325.
48. Jarrett T.W., Sweetser P.M., Weiss G.H., et al. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol. 154:1995;1629-1635.
49. Patel A., Fuchs G.J. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. J Urol. 159:1998;71-75.
50. Schoenberg M.P., Van Arsdalen K.N., Wein A.J. The management of transitional cell carcinoma in solitary renal units. J Urol. 146:1991;700-703.
51. Chen G.L., El-Gabry E.A., Bagley D.H. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology, and urinalysis. J Urol. 165:2000;1901-1904.
52. Chen G.L., Bagley D.H. Ureteroscopic surgery for upper tract transitional cell carcinoma: complications and management. J Endourol. 15:2001;399-404. 409.
53. Tomera K.M., Leary F.J., Zincke H. Pyeloscopy in urothelial tumors. J Urol. 127:1982;1088-1089.
54. McCarron J.P., Mills C., Vaughan E.D. Jr. Tumors of the renal pelvis and ureter: current concepts and management. Semin Urol. 1:1983;75-81.
55. Kulp D.A., Bagley D.H. Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma? J Endourol. 8:1994;111-113.
56. Hendin B.N., Streem S.B., Levin H.S., et al. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol. 161:1999;783-785.
57. Andrews P.A., Segura J.W. Renal pelvic explosion during conservative management of upper tract urothelial cancer. J Urol. 146:1991;407-408.
58. Johnson D.E. Treatment of distal ureteral tumors using endoscopic argon photoirradiation. Lasers Surg Med. 12:1992;490-493.
59. Tasca A., Zattoni F., Garbeglio A., et al. Endourologic treatment of transitional cell carcinoma of the upper urinary tract. J Endourol. 6:1992;253-256.
60. Kaufman R.P. Jr., Carson C.C. 3rd. Ureteroscopic management of transitional cell carcinoma of the ureter using the neodymium:YAG laser. Lasers Surg Med. 13:1993;625-628.
61. Gaboardi E., Bozzola A., Dotti E., et al. Conservative treatment of upper urinary tract tumors with Nd:YAG laser. J Endourol. 8:1994;37-41.
62. Engelmyer E.I., Belis J.A. Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract. Tech Urol. 2:1996;113-116.
63. Chen G.L., Bagley D.H. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol. 164:2000;1173-1176.
64. Elliott D.S., Segura J.W., Lightner D., et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 58:2001;174-178.